Production (Stage)
CardioComm Solutions, Inc.
EKG.V
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 18.50% | 41.66% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 18.50% | 41.66% | |||
| Cost of Revenue | 2,500.00% | -71.43% | |||
| Gross Profit | 8.80% | 43.88% | |||
| SG&A Expenses | -4.22% | -0.16% | |||
| Depreciation & Amortization | 7.69% | 1.96% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.88% | -0.83% | |||
| Operating Income | 48.60% | 52.25% | |||
| Income Before Tax | -16.55% | -11.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.55% | -11.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.55% | -11.15% | |||
| EBIT | 48.60% | 52.25% | |||
| EBITDA | 51.42% | 52.61% | |||
| EPS Basic | 0.00% | 0.00% | |||
| Normalized Basic EPS | 0.00% | 0.00% | |||
| EPS Diluted | 0.00% | 0.00% | |||
| Normalized Diluted EPS | 0.00% | 0.00% | |||
| Average Basic Shares Outstanding | 2.25% | 25.01% | |||
| Average Diluted Shares Outstanding | 2.25% | 25.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||